Darrell Ting Hung Li1, Edward Sai Kam Hui1, Queenie Chan2, Nailin Yao3, Siew-eng Chua4, Grainne M. McAlonan4,5, Shu Leong Ho6, and Henry Ka Fung Mak1
1Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong, Hong Kong, 2Philips Healthcare, Hong Kong, Hong Kong, 3Department of Psychiatry, Yale University, New Haven, CT, United States, 4Department of Psychiatry, The University of Hong Kong, Hong Kong, Hong Kong, 5Department of Forensic and Neurodevelopmental Science, King’s College London, London, United Kingdom, 6Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
Synopsis
Abnormal
iron accumulation in the brain may cause oxidative-stress-induced
neurodegeneration, which is one of the hypothesis of nigral cell death in PD.
It was also believed that non-motor symptoms of PD patients are associated with
the increased of brain iron content. This study examined the iron concentration
in several subcortical structures of PD patients with visual hallucinations by
using the QSM technique. Higher magnetic susceptibility was observed in the
hippocampus of this patient group. The result supported the hypothesis that hippocampal
abnormality could induce visuospatial memory impairment which may be the cause
of visual hallucination in PD patients.Purpose
Visual hallucinations is one of the major
non-motor comorbidities exists in some of the Parkinson’s disease (PD) patients
1. However, the underlying pathophysiology is yet to be understood.
Nigral iron deposition was postulated to be the cause of neurodegeneration of
the substantia nigra, and increased iron concentration was commonly observed in
substantia nigra of the PD patients
2-4. The aim of this study was
to examine the association between subcortical iron deposition in PD and the
development of visual hallucinations in the PD patients (PDVH).
Methods
77
subjects were recruited in this study, with 19 PDVH patients (15 males, mean
age ± S.D. = 71 ± 8 years, mean illness duration ± S.D. = 10 ± 4 years), 32 PD
patients without visual hallucinations (18 males, mean age ± S.D. = 63 ± 8
years, mean illness duration ± S.D. = 8 ± 5 years) and 26 healthy control
subjects (15 males, mean age ± S.D. = 62 ± 7 years). Susceptibility imaging
were performed on all subjects with the 3.0T
Philips scanner with the following parameters: 3D-T1FFE sequence, TR/TE = 28/23
ms, flip angle = 15°, NEX = 1, FOV = 230 x 230 x 180 mm
3,
reconstructed resolution = 0.45 x 0.45 x 1 mm
3. The raw phase images
were unwrapped with Laplacian-based algorithm and processed with ReSHARP to
removal the background field. The phase images were subsequently processed with
the total-variation-regularization algorithm to obtain the L1-norm
regularized QSM images
5, 6. Same session 3D-T1MPRAGE images, affine
registered to the subject’s native space, were processed with FSL-FIRST to
segment the subcortical structures. The six subcortical structures (bilateral
caudate nucleus, putamen, pallidum, thalamus, hippocampus and amygdala)
segmented (fig. 1) were used as the ROI to analyze both mean estimated volume
and the mean magnetic susceptibility of the corresponding structure. All values
were normalized to the averaged susceptibility values of the bilateral frontal
white matter regions.
Results
One-way
ANOVA of group mean age showed significant differences between group (p = 0.001).
Post-hoc test with Bonferroni correction suggested that mean age of the PDVH
group is significantly higher than that of the healthy (p = 0.001) and PD
groups (p = 0.002). Age and gender were then included as covariates in further
analyses for adjustment. One-way ANCOVA of the average estimated subcortical
volume did not show any significant difference when comparing the PDVH group
with the other two groups (fig. 2). One-way ANCOVA adjusting age and gender was
also employed to examine the difference in mean magnetic susceptibility of the
subcortical structures between groups. Significance was observed between groups
in bilateral hippocampus and thalamus (p < 0.005, for all). Post-hoc
multiple comparison with Bonferroni adjustment suggested that higher
susceptibility values observed in the PDVH groups when compared with the
healthy control in bilateral hippocampus (p < 0.001, both) and bilateral
thalamus (left: p = 0.002, right: p < 0.001); and compared with the PD group
in the right hippocampus (p = 0.028) (fig. 3).
Discussions
Preliminary
study of subcortical volume suggested no brain atrophy in the examined regions.
In measuring magnetic susceptibility of each subcortical nucleus, right
hippocampus was found to have significantly higher magnetic susceptibility in
the PDVH group compared to both PD and healthy group, suggesting possible iron
accumulation in this brain region. Abnormal iron accumulation in the brain is
postulated to be the cause of neuronal cell death by the mechanism of increased
oxidative stress to the cell
2. Hippocampus, which has a specialized
role in the consolidation of memories, is also associated with the function of
spatial navigation. In a recent study to examine the disease with both DTI and
resting-state fMRI, the hippocampal functional connectivity was reported to be altered
in the PDVH patients, postulated that the symptom of visual hallucinations was
due to the impairment of the visuospatial memory pathway of the hippocampus
1.
This study supported the previous study that hippocampus abnormality could be
involved in the onset of visual hallucinations in PD patients. On the other
hand, hippocampal magnetic susceptibility as a biomarker of the development of
visual hallucination in PD patients is worth further exploration.
Conclusion
PD patients
with visual hallucinations were found to have higher magnetic susceptibility, possibly
due to iron deposition, in hippocampus compared to healthy and the other PD
patients. High hippocampal magnetic susceptibility could be a biomarker to
examine the development of non-motor impairment, e.g. visual hallucination, in
PD patients. This study also supported the hypothesis that hippocampus
abnormality may induce visuospatial memory impairment which ultimately cause
visual hallucination in PD patients.
Acknowledgements
No acknowledgement found.References
1. Yao N,
et al. Multimodal MRI of the hippocampus in Parkinson’s disease with visual
hallucinations. Brain Struct Funct. 2014 Oct 7.
2. Du G.,
et al. Quantitative Susceptibility Mapping of the Midbrain in Parkinson’s
Disease. Mov Disord. 2015 Sep 12.
3. Murakami
Y., et al. Usefulness of Quantitative Susceptibility Mapping for Diagnosis of
Parkinson’s Disease. Am J Neuroradiol 2015 Jun; 36(6): 1102 – 08
4. Barbosa
JH., et al. Quantifying brain iron deposition in patients with Parkinson’s
disease using quantitative susceptibility mapping, R2 and R2*. Magn Reson
Imaging. 2015 Jun;33(5):559-65.
5. Bilgic
B, et al. MRI estimates of brain iron concentration in normal aging using
quantitative susceptibility mapping. NeuroImage 2012; 59: 2625-2635.
6. Bilgic
B, et al. Fast Quantitative Susceptibility Mapping with L1-Regularization and
Automatic Parameter Selection. Magn Reson Med. 2014 Nov; 72(5): 1444-59.